Evaluation of the efficacy of a combined regimen including an ER targeted therapy and ICB
Research Grant
Administered By
Pharmacology & Cancer Biology
Awarded By
Sermonix Pharmaceuticals
Start Date
August 21, 2023
End Date
July 31, 2024
Administered By
Pharmacology & Cancer Biology
Awarded By
Sermonix Pharmaceuticals
Start Date
August 21, 2023
End Date
July 31, 2024